WEN-JEN HWU to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications WEN-JEN HWU has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.687
-
The safety of temozolomide in the treatment of malignancies. Expert Opin Drug Saf. 2009 Jul; 8(4):493-9.
Score: 0.270
-
Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. Lancet Oncol. 2001 Oct; 2(10):634-5.
Score: 0.158
-
Molecular basis for thymidine modulation of the efficacy and toxicity of alkylating agents. Pharmacol Ther. 1997 Oct-Dec; 76(1-3):101-16.
Score: 0.120
-
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects. Cancer. 2010 Jun 15; 116(12):2868-77.
Score: 0.072
-
Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidine. Biochem Pharmacol. 1997 Mar 07; 53(5):705-13.
Score: 0.029
-
A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma. Melanoma Res. 2016 12; 26(6):604-608.
Score: 0.028
-
Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma. Melanoma Res. 2003 Apr; 13(2):189-96.
Score: 0.011